63 related articles for article (PubMed ID: 8833982)
1. Determination of the novel sialic acid analog GG167 (GR121167X) in human urine by liquid chromatography: direct injection with column switching.
Morris DM; Hussey BK; Geurin SL; Selinger KA
J Pharm Biomed Anal; 1995 Dec; 14(1-2):191-201. PubMed ID: 8833982
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.
Hayden FG; Treanor JJ; Betts RF; Lobo M; Esinhart JD; Hussey EK
JAMA; 1996 Jan 24-31; 275(4):295-9. PubMed ID: 8544269
[TBL] [Abstract][Full Text] [Related]
3. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
[TBL] [Abstract][Full Text] [Related]
4. Two neuraminidase inhibitors for treatment of influenza.
Med Lett Drugs Ther; 1999 Oct; 41(1063):91-3. PubMed ID: 10535051
[No Abstract] [Full Text] [Related]
5. Elderly people's technique in using dry powder inhalers. Zanamivir and unreason seem to go together.
Hall GH
BMJ; 2001 Jul; 323(7303):50. PubMed ID: 11464829
[No Abstract] [Full Text] [Related]
6. Zanamivir: from drug design to the clinic.
Elliott M
Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388
[TBL] [Abstract][Full Text] [Related]
7. Automated high-performance liquid chromatographic method for the determination of a neuraminidase inhibitor (GG167) in human serum by pre-column fluorescence derivatisation using benzoin.
Stubbs RJ; Harker AJ
J Chromatogr B Biomed Appl; 1995 Aug; 670(2):279-85. PubMed ID: 8548018
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatographic-tandem mass spectrometric method for the determination of the neuraminidase inhibitor zanamivir (GG167) in human serum.
Allen GD; Brookes ST; Barrow A; Dunn JA; Grosse CM
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):383-93. PubMed ID: 10517361
[TBL] [Abstract][Full Text] [Related]
9. [New diagnostic possibilities and medications. Fit for influenza?].
Wutzler P
MMW Fortschr Med; 2002 Nov; 144(48):18. PubMed ID: 12532540
[No Abstract] [Full Text] [Related]
10. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T
Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150
[TBL] [Abstract][Full Text] [Related]
11. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.
Buxton RC; Edwards B; Juo RR; Voyta JC; Tisdale M; Bethell RC
Anal Biochem; 2000 May; 280(2):291-300. PubMed ID: 10790313
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection.
Calfee DP; Peng AW; Hussey EK; Lobo M; Hayden FG
Antivir Ther; 1999; 4(3):143-9. PubMed ID: 12731753
[TBL] [Abstract][Full Text] [Related]
13. Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults.
Boivin G; Goyette N; Hardy I; Aoki F; Wagner A; Trottier S
J Infect Dis; 2000 Apr; 181(4):1471-4. PubMed ID: 10762579
[TBL] [Abstract][Full Text] [Related]
14. Determination of 2'-deoxy-3'-thiacytidine (3TC) in human urine by liquid chromatography: direct injection with column switching.
Morris DM; Selinger K
J Pharm Biomed Anal; 1994 Feb; 12(2):255-64. PubMed ID: 8003552
[TBL] [Abstract][Full Text] [Related]
15. Advances in pharmacology. New treatments for influenza: neuraminidase inhibitors.
Cross J; Wedekind CA
Med Health R I; 2001 Jun; 84(6):209-11. PubMed ID: 11434154
[No Abstract] [Full Text] [Related]
16. [Neuraminidase inhibitors against influenza].
Med Monatsschr Pharm; 1999 Sep; 22(9):262-4. PubMed ID: 10536414
[No Abstract] [Full Text] [Related]
17. GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets.
Ryan DM; Ticehurst J; Dempsey MH
Antimicrob Agents Chemother; 1995 Nov; 39(11):2583-4. PubMed ID: 8585752
[TBL] [Abstract][Full Text] [Related]
18. [Neuraminidase inhibitor permitted. The first pill against influenza].
MMW Fortschr Med; 2002 Oct; 144(41):56. PubMed ID: 12474367
[No Abstract] [Full Text] [Related]
19. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
Ferraris O; Kessler N; Lina B
Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799
[TBL] [Abstract][Full Text] [Related]
20. Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract.
Fenton RJ; Morley PJ; Owens IJ; Gower D; Parry S; Crossman L; Wong T
Antimicrob Agents Chemother; 1999 Nov; 43(11):2642-7. PubMed ID: 10543741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]